title: Synthetic hydrogels as carriers in antisense therapy: preliminary evaluation of an oligodeoxynucleotide covalent conjugate with a copolymer of 1-vinyl-2-pyrrolidinone and 2-hydroxyethyl methacrylate.
abstract: A major challenge of the antisense therapeutic strategies is the development of improved systems for the delivery of antisense oligodeoxynucleotides (AS ODNs) in order to enhance the cellular uptake, to assure a better efficiency in reaching the target tissue, and to provide sustained delivery over longer periods of time. Because the current methods for delivery (liposomes and cationic polymers) present some disadvantages, the attention was directed toward the use of neutral polymers as carriers for the AS ODNs. Based on our previous work on synthetic hydrogels for vitreous substitution, we developed a poly[1-vinyl-2-pyrrolidinone-co-(2-hydroxyethyl methacrylate)] hydrogel as a potential carrier for AS ODNs. We have previously demonstrated that such hydrogels are not cytotoxic, and they may have growth-promoting effects on cultured fibroblasts. This copolymer also has the advantage of being injectable. In this study, a specific AS ODN was synthesized and then covalently bound to the copolymer via carbodiimide coupling method. The resulting conjugate was subjected to in vitro release experiments over 46 days in the presence of bovine vitreous humor. Compared with the control (no enzyme present), a significant amount of covalently bound ODN was released from the ODN-hydrogel conjugate, suggesting the possibility of using such systems for the sustained delivery of AS ODNs.
authors.affiliation: Lions Eye Institute, Department of Biomaterials & Polymer Research, University of Western Australia, Nedlands, Australia.
authors.forename: X
authors.initials: X
authors.lastname: Lou
authors.forename: K L
authors.initials: KL
authors.lastname: Garrett
authors.forename: P E
authors.initials: PE
authors.lastname: Rakoczy
authors.forename: T V
authors.initials: TV
authors.lastname: Chirila
mesh_terms: D001483:Base Sequence; D017931:DNA Primers; D004337:Drug Carriers; D020100:Hydrogels; D008689:Methacrylates / Q000737:chemistry*; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage* / Q000737:chemistry; D011759:Pyrrolidines / Q000737:chemistry*; D013056:Spectrophotometry, Ultraviolet; D017550:Spectroscopy, Fourier Transform Infrared
chemical_list: D017931:DNA Primers; D004337:Drug Carriers; D020100:Hydrogels; D008689:Methacrylates; D016376:Oligonucleotides, Antisense; D011759:Pyrrolidines; C437923:poly(1-vinyl-2-pyrrolidinone-co-(2-hydroxyethyl methacrylate))